日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases

发现并表征临床阶段双特异性 TNF/IL-17A 抑制剂 COVA322,用于治疗炎症疾病

Michela Silacci, Wibke Lembke, Richard Woods, Isabella Attinger-Toller, Nadja Baenziger-Tobler, Sarah Batey, Roger Santimaria, Ulrike von der Bey, Susann Koenig-Friedrich, Wenjuan Zha, Bernd Schlereth, Mathias Locher, Julian Bertschinger, Dragan Grabulovski

Exchanging human Fcgamma1 with murine Fcgamma2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model

在同源小鼠肺转移模型中,用鼠 Fcgamma2a 替换人类 Fcgamma1 可高度增强抗 EpCAM 抗体 adecatumumab 的抗肿瘤活性

Petra Lutterbuese, Klaus Brischwein, Robert Hofmeister, Sandrine Crommer, Grit Lorenczewski, Laetitia Petersen, Sandra Lippold, Antonio da Silva, Mathias Locher, Patrick A Baeuerle, Bernd Schlereth